The Bradley Group would like to recognise the following research partners for their funding and financial support of our work.
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Further information on our research funding can be found below and via this page.
ADREEM: Adding Another Dimension - Arrays of 3D Bio-Responsive materials
Bradley, M.
1/11/14 > 30/09/15
£1,711,766, EU government bodies
Smart materials for targeted stem cell fate and function in skeletal repair
Bradley, M.
31/03/14 > 30/03/17
£374,075, BBSRC
HumEn Project (RTD)
Bickmore, W. & Bradley, M.
1/01/14 > 31/12/17
£828,061, EU government bodies
IMAGFIB: Imaging Fibrosis - Chemistry and Optical Confocal Laser Endomicroscopy
Bradley, M.
1/10/13 > 30/09/15
£171,321, EU government bodies
Multiplexed 'Touch and Tell' Optical Molecular Sensing and Imaging
Bradley, M., Henderson, R., Dhaliwal, K., Haslett, C. & Williams, C.
1/10/13 > 30/09/18
£5,271,731, EPSRC
CLEDEPOLY: Tissue Specific Delivery via Cleavable and Degradable Polymers
Bradley, M.
1/07/13 > 30/06/15
£164,153, EU government bodies
Implantable Microsystems for Personalised Anti-Cancer Therapy
Murray, A., Walton, A., Bradley, M., Argyle, D., Smith, S., Tait, J. & Haddow, G.
27/05/13 > 26/05/18
£2,391,469, EPSRC
A new paradigm for testing pathway tractability in lung disease
Hirani, N., Dhaliwal, K., Haslett, C. & Bradley, M.
1/05/13 > 30/04/16
£295,453, MRC
Chemical Strategies for Epigenome wide discrimination of 5-hydroxymethylcytosine and 5-methylcytosine
Bradley, M. & De Sousa, P.
1/11/12 > 31/10/15
£662,136, EPSRC
Molecular Optical Imaging of Key Targets in the Fibrogenic Pathway in Man
Bradley, M., Dhaliwal, K., Haslett, C., Hirani, N. & McGorum, B.
1/09/12 > 31/12/15
£971,797, MRC